Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - takuya+maeda
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Personalized Medicine Using Additive Manufacturing
THE CHALLENGE A major problem posed by the pharmaceutical industry is giving effective dosages while not giving excessive amounts of a particular drug. An estimated 80% of side effects in humans and animals are a direct result of inaccurate dosing because varying weights in patients. Additive manufacturing has emerged as a very promising method to...
Published: 6/26/2025
|
Updated: 10/2/2023
|
Inventor(s):
Emily Wilts
,
Timothy Long
,
Christopher Williams
,
Da Ma
Keywords(s):
Category(s):
Technology Classifications > Additive Manufacturing
,
Technology Classifications > Biomedical
,
Technology Classifications > Chemicals/Materials
,
Technology Classifications > Pharmacology and Therapeutics
High-Throughput Generation of Induced Pluripotent Stem Cells Carrying Antigen-Specific T Cell Receptors from Tumor Infiltrated Lymphocytes
Summary: NCI seeks proposals from parties interested in licensing an improved method for the identification of TCRs from bulk populations of TIL for the development of cancer immunotherapies. Description of Technology: One form of adoptive T cell therapy (ACT) consists of harvesting tumor infiltrating lymphocytes (TIL), screening and isolating TIL...
Published: 4/24/2026
|
Updated: 8/2/2023
|
Inventor(s):
Raul Sakoda
,
S M Rafiqul Islam
,
Naritaka Tamaoki
,
Takuya Maeda
,
Nicholas Restifo
Keywords(s):
act
,
adoptive cell therapy
,
ANTIGEN-SPECIFIC
,
Cancer Targets
,
Immunotherapy
,
Induced Pluripotent Stem Cells
,
iPSC
,
Restifo
,
Rosenberg
,
T Cell Receptors
,
TCR
,
TIL
,
Tumor Infiltrated Lymphocytes
Category(s):
TherapeuticArea > Oncology
,
TherapeuticArea > Immunology
,
Application > Therapeutics
,
Collaboration Sought > Licensing